KuartisMED
Çankaya
About KuartisMED
KuartisMED is a biomedical company developing products for the well-being of preterm infants. It developed Premades, a monitoring feeding ability for newborns. KuartisMED is a proud Horizon 2020 SME Instrument grantee. Its banner product has received a Phase-2 grant for the “SMEInst-12-2016-2017 ’ New business models for inclusive, innovative and reflective societies” which is awarded from the European Union’s Horizon 2020 research and innovation program. The company had previously received H2020 SME Instrument Phase-1 grant in 2014 for the Feasibility Study and Commercialization Plan for PREMADES.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.4M
- Funding stage: Seed
- Last round: Seed (Nov 2022)
- Website: kuartismed.com
- Phone: +90 312-241-4045
Industries & Categories
Baby, Biotechnology, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/kuartismed-134345 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.